The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications
Clinical and Translational Science, Volume 19, Issue 2, February 2026.ABSTRACT Ecopipam is a first‐in‐class dopamine D1 receptor antagonist under investigation for the treatment of Tourette syndrome. This open‐label, fixed‐sequence, three‐cohort study evaluated whether ecopipam induces or inhibits cytochrome P450 (CYP) 1A2, CYP2B6, CYP2C19, CYP2D6, CYP3A4, organic anion‐transporting polypeptide (OATP) 1B1, and p ...
Virginia D. Schmith +4 more
wiley +1 more source
Equine Veterinary Education, Volume 38, Issue 2, Page e70-e77, February 2026.Summary Two foals were being treated with a combination of oral doxycycline and rifampin for presumed Rhodococcus equi infections. After 3–4 weeks of antimicrobial administration, both foals presented with icterus and nonspecific clinical signs, including lethargy and inappetence.
A. Murdock +7 more
wiley +1 more source
Current Issues in Molecular BiologyAntibiotic resistance in Helicobacter pylori is increasing rapidly and emerging as a major factor in treatment failure. We aimed to identify genetic mutations associated with resistance to clarithromycin (23S rRNA peptidyl transferase), fluoroquinolones (
Pedro Valada +5 more
doaj +1 more source
PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin [PDF]
, 1997 Gregory G. Stone +5 more
openalex +1 more source
Seven‐day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride [PDF]
, 1997 Matthew P. Williams +3 more
openalex +1 more source
Best of United European Gastroenterology Week 2025
United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
Iuliana Nenu +3 more
wiley +1 more source
Cultural Recovery and Determination of Antimicrobial Susceptibility in Helicobacter pylori by Using Commercial Transport and Isolation Media [PDF]
, 2018 : Background: : Antimicrobial resistance of Helicobacter pylori is the main reason for eradication failure. We have studied the feasibility of a commercial transport medium for cultural recovery and subsequent drug susceptibility testing.
Bauerfeind, P. +4 more
core
Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Helicobacter pylori Therapy [PDF]
David Y. Graham
openalex +1 more source
Chitosan-Genipin Microspheres for the Controlled Release of Drugs: Clarithromycin, Tramadol and Heparin [PDF]
, 2010 Ruth Harris +2 more
openalex +1 more source
MACROLIDE-CLARITHROMYCIN TASK-FORCE FOR THE TREATMENT AND PROPHYLAXIS OF COVID-19 AS A SINGLE AGENT. [PDF]
, 2020 Eduardo Mansilla
openalex +1 more source